154Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
South Korea
Neuroscience Intelligence
South Korea neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #15 of 50 · Data maturity A · Research score 41.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:36 UTC.
45Recruiting trials
185Publications
102Institutions
Executive interpretation
South Korea ranks #15 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC189 recruiting
Hoffmann-La Roche103 recruiting
Seoul National University Hospital101 recruiting
Samsung Medical Center70 recruiting
Yonsei University61 recruiting
Pfizer51 recruiting
GlaxoSmithKline50 recruiting
Eli Lilly and Company41 recruiting
AbbVie41 recruiting
Bayer32 recruiting
Disease activity
Alzheimers31trials
Parkinsons28trials
Stroke15trials
Epilepsy14trials
Depression7trials
Neuromuscular6trials
Schizophrenia6trials
Autism5trials
Adhd4trials
Migraine Headache3trials
Research institutions
Seoul Metropolitan GovernmentOpenAlexlinked institution
SNUH SMG-SNU Boramae Medical CenterOpenAlexlinked institution
Severance HospitalOpenAlexlinked institution
Ajou UniversityOpenAlexlinked institution
Samsung Biomedical Research InstituteOpenAlexlinked institution
Keimyung UniversityOpenAlexlinked institution
Hallym University Kangnam Sacred Heart HospitalOpenAlexlinked institution
NovaCell Technology (South Korea)OpenAlexlinked institution
Dankook University HospitalOpenAlexlinked institution
Korea Railroad Research InstituteOpenAlexlinked institution
Clinical evidence trail
NCT07764874Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.NOT_YET_RECRUITING
NCT07728864Sexuality and Relationship Education for Autistic Adults: Our Love, Our StyleACTIVE_NOT_RECRUITING
NCT07589595A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)RECRUITING
NCT07529574Efficacy and Safety of a Theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant DepressionNOT_YET_RECRUITING
NCT07252739KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RECRUITING
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07033494A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)RECRUITING
Research evidence trail
PUBMEDAssociations between human oxytocin receptor gene promoter DNA methylation and brain structural connectome in panic disorder in Korea.2026-12-15
PUBMEDMapping topological abnormalities in cortical similarity networks to schizophrenia-associated gene expression.2026-12-01
PUBMEDGraph neural network-based modeling of functional brain connectivity in autism spectrum disorder using the ABIDE-I and II datasets.2026-12-01
PUBMEDDifferential linguistic patterns across Rorschach, TAT, and SCT in individuals with PTSD.2026-12-01
PUBMEDTRPA1 antagonism reveals sex-specific mechanisms in morphine withdrawal-induced negative emotional behavior via dopaminergic pathway.2026-11-15
PUBMEDSchema mode profiles and lifetime suicide attempts in patients with mood disorders in full remission: A latent profile analysis.2026-11-15
PUBMEDBody composition profiles and metabolic vulnerability in comorbid insomnia and sleep apnea (COMISA): A large-scale BIA analysis.2026-11-01
PUBMEDClinical and genetic association of comorbid provisional PMDD and ADHD in female patients with bipolar disorder.2026-11-01
PUBMEDResting-state functional connectome correlates of suicide attempt history and childhood trauma in major depressive disorder.2026-11-01
PUBMEDPreliminary efficacy of a self-guided mobile intervention for reducing stress in depression: A randomized controlled crossover trial.2026-11-01
PUBMEDWeek-ahead prediction of depressive episodes using wearable-derived circadian biomarkers: A multicenter deep learning study with risk-based operating thresholds.2026-11-01
PUBMEDDistinctive lexical profiles in Korean-speaking patients with schizophrenia: Analysis of verbal productivity, lexical diversity, and part-of-speech distributions.2026-11-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.